<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-2VXLC5ET/79145e12-bacb-4eb2-8ec9-ac243a923963/HTML"><dcterms:extent>35 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-2VXLC5ET/d14f1e4e-1a92-4d86-92d4-ed34b54ab2e6/PDF"><dcterms:extent>544 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-2VXLC5ET/3118e00d-6995-4ed5-be4c-0c12b6574c37/TEXT"><dcterms:extent>32 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-2VXLC5ET"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2009</dcterms:issued><dc:creator>Fon Tacer, Klementina</dc:creator><dc:format xml:lang="sl">številka:6/7</dc:format><dc:format xml:lang="sl">letnik:78</dc:format><dc:format xml:lang="sl">str. 309-314</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:25803993</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-2VXLC5ET</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="en">Aging</dc:subject><dc:subject xml:lang="en">Bile Acids And Salts</dc:subject><dc:subject xml:lang="sl">Citokrom P-450</dc:subject><dc:subject xml:lang="en">Cytochrome P-450</dc:subject><dc:subject xml:lang="sl">endokrinologija</dc:subject><dc:subject xml:lang="en">Fatty Acids</dc:subject><dc:subject xml:lang="en">Fibroblast Growth Factor</dc:subject><dc:subject xml:lang="sl">Fibroblastni, rastni faktor</dc:subject><dc:subject xml:lang="sl">fiziologija</dc:subject><dc:subject xml:lang="sl">Fosfati</dc:subject><dc:subject xml:lang="sl">Maščobne kisline</dc:subject><dc:subject xml:lang="sl">metabiločni sindrom</dc:subject><dc:subject xml:lang="en">Metabolic Diseases</dc:subject><dc:subject xml:lang="en">Metabolism</dc:subject><dc:subject xml:lang="en">Phosphates</dc:subject><dc:subject xml:lang="sl">presnova</dc:subject><dc:subject xml:lang="sl">Presnovne bolezni</dc:subject><dc:subject xml:lang="sl">Staranje</dc:subject><dc:subject xml:lang="en">Transcription Factors</dc:subject><dc:subject xml:lang="sl">Transkripcija, faktorji</dc:subject><dc:subject xml:lang="sl">Vitamin D</dc:subject><dc:subject xml:lang="sl">žolčne kisline</dc:subject><dc:subject xml:lang="sl">Žolčne kisline in soli</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Citokromi P450, jedrni receptorji in fibroblastni rastni dejavniki - nove endokrine osi kot potencialna prijemališča za zdravljenje presnovnih bolezni| Cytochromes P450, nuclear receptors, and fibroblast growth factors - new endocrine axes as potential drug targets to treat metabolic disorders|</dc:title><dc:description xml:lang="sl">Coordinate action of endocrine and nervous system enables adaptation of higherorganisms to constant changes in the environment. Fibroblast growth factors (FGFs) primarily regulate embryonic and organ development, however, FGF19 subfamily members despite the name act in an endocrine fashion. The studies of endocrine FGFs resulted in the discovery of new endocrine axes, composed of small lipophilic molecules and members of three protein families: cytochromes P450, nuclear receptors, and FGFs. Cytochromes P450 are enzymes responsible for metabolism of different lipid molecules. Nuclear receptors bind lipid metabolites and act as metabolic sensors. They become activated andas transcriptional factors turn on expression of endocrine FGFs. eFGFs regulate metabolic pathways in target organs that express specific FGF receptor/coreceptor pair. FGF15/19 is expressed in the small intestine and is involved in the postprandial bile acid negative feedback loop in the liver. FGF21 is liver-borne fasting hormone that induces fat utilization. FGF23 is expressed in bone and acts on kidney to regulate phosphate and vitamin D metabolism. We describe herein three new endocrine axes that were probably developed for fine tuning metabolite concentration within narrow physiologicallimits and prevent their toxicity in excess. They play important role in the pathophysiology underlying diverse metabolic disorders and are expected to be potential targets for therapeutic interventions</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-2VXLC5ET"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-2VXLC5ET" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-2VXLC5ET/d14f1e4e-1a92-4d86-92d4-ed34b54ab2e6/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-2VXLC5ET/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-2VXLC5ET" /></ore:Aggregation></rdf:RDF>